Late Effects of Cancer Treatment — MCQs
Cardiotoxicity caused by radiotherapy & chemotherapy is best detected by
Radiation exposure can lead to which type of thyroid carcinoma?
Which is the commonest childhood cancer –
Mantle Field Radiotherapy is generally used in treatment of?
Extent of cardiotoxicity of chemotherapy and radiotherapy is best diagnosed by:
What is the average time interval between radiation exposure and genesis of post-radiation osteosarcoma?
Late effects of radiation therapy include:
Which of the following malignant diseases of children has the best prognosis -
Bragg peak effect is most noticeable in which of the following?
Screening for colorectal cancer is recommended when?
Late Effects of Cancer Treatment Indian Medical PG Practice Questions and MCQs
Question 1: Cardiotoxicity caused by radiotherapy & chemotherapy is best detected by
- A. ECHO (Correct Answer)
- B. Endomyocardial Biopsy
- C. ECG
- D. Radionuclide Scan
Explanation: ***ECHO*** - **Echocardiography (ECHO)** is the primary and most widely used non-invasive method for detecting cardiotoxicity due to its ability to assess **left ventricular ejection fraction (LVEF)**, a key indicator of cardiac function, and structural changes. - It is crucial for **baseline assessment**, monitoring during treatment, and follow-up, identifying both systolic and diastolic dysfunction effectively. *Endomyocardial Biopsy* - While **endomyocardial biopsy** is considered the gold standard for definitive diagnosis of some cardiomyopathies (e.g., myocarditis), it is **invasive** and carries risks such as perforation, tamponade, and arrhythmias. - It is usually reserved for cases where other non-invasive tests are inconclusive and there's a strong clinical suspicion of severe cardiac disease, or for research, not routine monitoring of cardiotoxicity. *ECG* - An **ECG** can detect arrhythmias and ischemic changes but is **not sensitive or specific** enough to reliably detect early or subtle changes in cardiac function characteristic of cardiotoxicity. - It may show changes secondary to heart failure, but it does not directly measure ejection fraction or assess overall cardiac mechanical function. *Radionuclide Scan* - **Radionuclide scans**, specifically **MUGA (Multigated Acquisition)** scans, can accurately measure **LVEF** and are an alternative to ECHO, particularly when ECHO images are suboptimal [1]. - However, they involve **radiation exposure**, making them less ideal for frequent monitoring compared to echocardiography, especially in cancer patients who are already exposed to radiation.
Question 2: Radiation exposure can lead to which type of thyroid carcinoma?
- A. Lymphoma
- B. Papillary carcinoma (Correct Answer)
- C. Medullary carcinoma
- D. Follicular carcinoma
Explanation: ***Papillary carcinoma*** - Papillary thyroid carcinoma is strongly associated with **radiation exposure**, particularly during childhood [1]. - It is the most prevalent type of thyroid cancer and typically has a **good prognosis** [1]. *Lymphoma* - Thyroid lymphoma is rare and generally not linked to **radiation exposure**; it often presents as a **rapidly enlarging goiter**. - It is more commonly associated with **autoimmune thyroiditis**, not primary radiation effects. *Follicular carcinoma* - Follicular carcinoma shows a correlation with **iodine deficiency** rather than radiation exposure [1]. - Its presentation is more subtle, compared to the classical association of **radiation with papillary carcinoma**. *Medullary carcinoma* - Medullary thyroid carcinoma is primarily linked to **familial syndromes** like MEN 2 and not radiation exposure. - It arises from **parafollicular C cells**, making it clinically distinct from radiation-related types. **References:** [1] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. The Endocrine System, pp. 1098-1099.
Question 3: Which is the commonest childhood cancer –
- A. AML
- B. CML
- C. CLL
- D. ALL (Correct Answer)
Explanation: ***ALL*** - **Acute Lymphoblastic Leukemia (ALL)** is the most common cancer in children, accounting for about 1 in 3 childhood cancers. - It primarily affects **lymphoid progenitor cells** and is characterized by rapid progression. *AML* - **Acute Myeloid Leukemia (AML)** is more common in adults and has a lower incidence in children compared to ALL. - It involves the **myeloid lineage** of white blood cells. *CML* - **Chronic Myeloid Leukemia (CML)** is rare in childhood, primarily affecting adults. - It is often associated with the **Philadelphia chromosome (BCR-ABL fusion gene)**. *CLL* - **Chronic Lymphocytic Leukemia (CLL)** is extremely rare in children and predominantly affects older adults. - It is characterized by the accumulation of **mature B lymphocytes**.
Question 4: Mantle Field Radiotherapy is generally used in treatment of?
- A. Breast carcinoma
- B. Hodgkins Lymphoma (Correct Answer)
- C. Neuroblastoma
- D. Lung cancer
Explanation: **Hodgkins Lymphoma** - **Mantle field radiotherapy** is a classic technique used to treat Hodgkin's lymphoma, particularly when the disease is localized to the **mediastinum, neck, and axillary lymph nodes** [1]. - This field encompasses the major lymphatic regions above the diaphragm, providing comprehensive treatment for common sites of involvement without exceeding dose limits to critical organs [1]. *Breast carcinoma* - Treatment for **breast carcinoma** typically involves surgery, chemotherapy, and localized radiation therapy to the breast and regional lymph nodes (axillary, supraclavicular, internal mammary), but not a widespread "mantle field." - Radiation fields for breast cancer are more specific to the breast tissue and regional nodes, aiming to minimize cardiac and pulmonary toxicity. *Neuroblastoma* - **Neuroblastoma** is a childhood cancer originating from neural crest cells and typically involves the adrenal glands or sympathetic ganglia; its treatment involves surgery, chemotherapy, and sometimes localized radiation, not mantle fields. - Radiation therapy for neuroblastoma is usually directed at specific tumor sites, such as the abdomen or chest, with techniques tailored to spare developing organs. *Lung cancer* - **Lung cancer** radiation therapy focuses on the primary tumor in the lung and involved mediastinal lymph nodes, using highly conformal techniques like IMRT or SBRT [2]. - A "mantle field" would be too broad and deliver unnecessary radiation to healthy lung tissue and other structures, increasing toxicity without improving outcomes for lung cancer.
Question 5: Extent of cardiotoxicity of chemotherapy and radiotherapy is best diagnosed by:
- A. Radionuclide scan
- B. ECG
- C. Echocardiogram (Correct Answer)
- D. Endomyocardial biopsy
Explanation: Echocardiogram - An echocardiogram is the most common and widely used non-invasive diagnostic tool to assess cardiac function and structure, including left ventricular ejection fraction (LVEF), which is crucial for monitoring cardiotoxicity [1]. - It can detect changes in ventricular size, wall motion abnormalities, and valvular function that may arise from chemotherapy or radiotherapy-induced damage [1]. Radionuclide scan - Radionuclide scans, such as MUGA (Multigated Acquisition) scans, can also assess LVEF but involve radiation exposure and are generally reserved for cases where echocardiography is suboptimal or yields equivocal results. - While sensitive, it's not the primary or initial diagnostic test due to its invasive nature and cost compared to echocardiography. ECG - An ECG (electrocardiogram) assesses the electrical activity of the heart but provides limited information about structural or functional changes indicative of cardiotoxicity [2]. - It can detect arrhythmias or ischemic changes but is not specific enough to determine the extent of myocardial damage from chemotherapy or radiotherapy [2]. Endomyocardial biopsy - Endomyocardial biopsy is an invasive procedure that provides a definitive histological diagnosis of myocardial damage but is rarely performed due to its invasiveness, risk of complications, and the availability of less invasive methods. - It is typically reserved for unexplained severe cardiac dysfunction or for specific research protocols, not routine monitoring of cardiotoxicity.
Question 6: What is the average time interval between radiation exposure and genesis of post-radiation osteosarcoma?
- A. 16 yrs (Correct Answer)
- B. 4 yrs
- C. 8 yrs
- D. 2 yrs
Explanation: ***16 yrs*** - The latency period for **radiation-induced osteosarcomas** is typically long, often exceeding a decade. - Studies have shown the average interval between therapeutic radiation and the development of osteosarcoma to be around **10-20 years**, with 16 years being a well-supported average. *4 yrs* - A 4-year interval is generally too short for the development of a **secondary osteosarcoma** after radiation exposure. - While other radiation-induced pathologies might manifest earlier, the transformation to osteosarcoma requires a sustained period of genetic damage and cellular changes. *8 yrs* - An 8-year latency period is still relatively short for most radiation-induced osteosarcomas to develop. - While some cases might occur within this timeframe, the average and modal latency periods are typically longer, reflecting the multi-step process of **carcinogenesis**. *2 yrs* - A 2-year interval is exceptionally rare for the development of a **radiation-induced osteosarcoma**. - This short period does not align with the known biological mechanisms and latency associated with radiation-induced bone malignancies.
Question 7: Late effects of radiation therapy include:
- A. Mucositis, Enteritis, Nausea and vomiting, Pneumonitis
- B. Enteritis, Nausea and vomiting, Pneumonitis, Somatic mutations
- C. Mucositis, Nausea and vomiting, Pneumonitis, Somatic mutations
- D. Mucositis, Enteritis, Pneumonitis, Somatic mutations (Correct Answer)
Explanation: ***Mucositis, Enteritis, Pneumonitis, Somatic mutations*** - **Somatic mutations** leading to **secondary malignancies** are a classic late effect of radiation (occurs years after exposure due to DNA damage) [1] - **Radiation pneumonitis** progressing to **pulmonary fibrosis** is a well-recognized late complication (typically 1-3 months to years post-treatment) [1] - **Chronic radiation enteritis** with fibrosis and vascular damage can occur months to years after abdominal/pelvic radiation [1] - **Chronic mucositis** with fibrosis can persist as a late effect, though mucositis is more commonly acute - This option represents the **most comprehensive list of late effects** among the choices *Mucositis, Enteritis, Nausea and vomiting, Pneumonitis* - **Nausea and vomiting** are predominantly **acute side effects** occurring during or immediately after radiation therapy, not late effects - While mucositis and enteritis can have chronic forms, including nausea/vomiting makes this option incorrect *Enteritis, Nausea and vomiting, Pneumonitis, Somatic mutations* - Incorrectly includes **nausea and vomiting** as a late effect - Though it includes somatic mutations (correct late effect), the presence of an acute symptom invalidates this choice *Mucositis, Nausea and vomiting, Pneumonitis, Somatic mutations* - Incorrectly includes **nausea and vomiting** as a late effect - Omits enteritis, which can manifest as chronic radiation enteritis with fibrosis and strictures **References:** [1] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Central Nervous System Synapse, pp. 437-439.
Question 8: Which of the following malignant diseases of children has the best prognosis -
- A. Primitive neuroectodermal tumor
- B. Wilms tumor (Correct Answer)
- C. Neuroblastoma
- D. Rhabdomyosarcoma
Explanation: ***Wilms tumor*** - **Wilms tumor**, also known as **nephroblastoma**, has one of the best prognoses among childhood malignancies, with a **survival rate exceeding 90%** for localized disease. - Its high curability is attributed to its **chemosensitivity**, surgical resectability, and advancements in multimodal therapy. *Primitive neuroectodermal tumor* - **Primitive neuroectodermal tumors (PNETs)** are highly aggressive and often associated with a **poor prognosis**, particularly when they are large or metastatic. - These tumors arise from neuroectoderm and can occur in the central nervous system (e.g., medulloblastoma) or peripherally, making treatment challenging due to their infiltrative nature. *Neuroblastoma* - **Neuroblastoma** is a common extracranial solid tumor in children, originating from neural crest cells, and its prognosis varies widely based on age, stage, and biological features, but it often has a **guarded prognosis**, especially in older children or with unfavorable genetic markers. - High-risk neuroblastomas frequently exhibit **amplification of the MYCN oncogene** and often require intensive, multi-modal treatment, still leading to significant mortality. *Rhabdomyosarcoma* - **Rhabdomyosarcoma** is a malignant tumor of mesenchymal origin with skeletal muscle differentiation, and its prognosis depends heavily on site, histology (e.g., alveolar vs. embryonal), and resectability, with **overall survival rates lower than Wilms tumor**, especially for unfavorable subtypes or metastatic disease. - Aggressive treatment including chemotherapy, radiation, and surgery is often necessary, but recurrence rates can be high.
Question 9: Bragg peak effect is most noticeable in which of the following?
- A. Electron beam
- B. Proton (Correct Answer)
- C. X-ray radiation
- D. Neutron radiation
Explanation: ***Proton*** - The **Bragg peak effect** describes the phenomenon where charged particles, like protons, deposit most of their energy at the end of their range, resulting in a sharply defined dose distribution. - This characteristic makes **proton therapy** highly advantageous in radiation oncology for targeting tumors precisely while sparing surrounding healthy tissues. *Electron beam* - **Electron beams** exhibit a more gradual dose fall-off with depth compared to protons and lack a distinct Bragg peak. - They are primarily used for treating **superficial tumors** due to their limited penetration depth. *X-ray radiation* - **X-rays** are uncharged photons that deposit energy more diffusely along their path, resulting in an exponential attenuation of dose rather than a sharp peak. - This makes them less precise in deeply seated tumors compared to therapies utilizing the Bragg peak. *Neutron radiation* - **Neutrons** are uncharged particles that deposit energy through nuclear reactions, leading to a complex dose distribution. - Similar to X-rays, they do not exhibit a distinct Bragg peak effect but are used in specialized cancer treatments for their high linear energy transfer.
Question 10: Screening for colorectal cancer is recommended when?
- A. The condition has a low case fatality rate.
- B. Diagnostic tools are not available.
- C. There is no effective treatment available.
- D. Early diagnosis can change the disease course due to effective treatment. (Correct Answer)
Explanation: ***Early diagnosis can change the disease course due to effective treatment.*** - Screening is primarily recommended when **early detection** allows for interventions that effectively alter the natural history of the disease, improving prognosis or preventing progression. - For colorectal cancer, early diagnosis through screening allows for timely removal of **precancerous polyps** or early-stage cancers, significantly increasing survival rates. *The condition has a low case fatality rate.* - Conditions with low case fatality rates generally do not warrant extensive screening programs, as the **benefit-to-harm ratio** is often unfavorable. - Colorectal cancer, if undiagnosed and untreated, has a significant **case fatality rate**, making screening beneficial. *Diagnostic tools are not available.* - Screening is only conducted when **reliable, accurate, and cost-effective diagnostic tools** are available to detect the disease or its precursors in asymptomatic individuals. - If diagnostic tools are unavailable, screening would be impossible or ineffective, as there would be no way to identify those with the condition. *There is no effective treatment available.* - Screening is not typically recommended for diseases for which there is **no effective treatment**, as early detection would not improve patient outcomes. - The primary purpose of screening is to identify individuals who can benefit from **early intervention** and treatment to prevent serious morbidity or mortality.
Want unlimited practice?
Get full access to all questions, explanations, and performance tracking.
Start For Free